Company Filing History:
Years Active: 2014-2017
Title: The Innovative Contributions of Stefan Koep
Introduction
Stefan Koep is a notable inventor based in Ennepetal, Germany. He has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds aimed at treating various diseases. With a total of 2 patents to his name, Koep's work is recognized for its potential impact on healthcare.
Latest Patents
Koep's latest patents include innovative compounds such as substituted sodium-1H-pyrazole-5-olate. This application relates to sodium 1-[6-(morpholin-4-yl)pyrimidin-4-yl]-4-(1H-1,2,3-triazol-1-yl)-1H-pyrazol-5-olate. The patent details processes for its preparation and its use in the treatment and/or prophylaxis of diseases, particularly cardiovascular, haematological, and kidney diseases. Additionally, it highlights its potential for promoting wound healing.
Career Highlights
Stefan Koep is currently associated with Bayer Intellectual Property GmbH, where he continues to innovate and develop new medicinal compounds. His work is characterized by a strong focus on improving therapeutic options for patients suffering from serious health conditions.
Collaborations
Koep collaborates with esteemed colleagues such as Hans-Christian Militzer and Jörg Gries, contributing to a dynamic research environment that fosters innovation and discovery.
Conclusion
Stefan Koep's contributions to medicinal chemistry through his patents and collaborations highlight his commitment to advancing healthcare solutions. His work exemplifies the importance of innovation in addressing critical health challenges.